Hypoxic-ischemic encephalopathy is a serious neurologic condition caused by reduced blood and oxygen supply to the brain, typically occurring during birth. Mitochondria play a crucial role in the pathophysiological mechanisms of hypoxic-ischemic encephalopathy, yet a comprehensive bibliometric analysis of this research area is lacking. This study aims to identify research hotspots and trends related to mitochondria and hypoxic-ischemic encephalopathy through a detailed bibliometric analysis.
Methods
We searched the Web of Science Core Collection for studies on hypoxic-ischemic encephalopathy and mitochondria published between 2004 and 2024. Using VOSviewer, Citespace, and the R package “bibliometrix,” we conducted a comprehensive analysis to explore research trends, key topics, and collaborations.
Results
A total of 162 eligible articles were identified. The annual number of publications has increased over time, with peaks in recent years. The top contributing countries were China, the United States, and the United Kingdom, showing extensive international collaborations. Major institutions include Augusta University, Southern Medical University, and the University of the Basque Country. The leading journals were the International Journal of Molecular Sciences and Neurobiology of Disease. Keyword analysis highlighted neuroprotection, apoptosis, oxidative stress, and ferroptosis as primary research themes. Influential references with strong citation bursts were identified, indicating their impact on the field.
Conclusion
This is the first bibliometric analysis of research on mitochondria and hypoxic-ischemic encephalopathy, highlighting key trends and hotspots. Our findings provide valuable insights into the development and direction of research in this field and emphasize the importance of mitochondria in understanding and potentially mitigating the impacts of hypoxic-ischemic encephalopathy.
WuLChangEZhaoHMaD. Regulated cell death in hypoxic-ischaemic encephalopathy: recent development and mechanistic overview. Cell Death Discov.2024;10(1):277.
2.
GrecoPNenciniGPivaI, et al.Pathophysiology of hypoxic-ischemic encephalopathy: a review of the past and a view on the future. Acta Neurol Belg.2020;120(2):277–288.
3.
NatarajanGPappasAShankaranS. Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE). Semin Perinatol.2016;40(8):549–555.
4.
ChawlaD. Biomarkers for prognostication in hypoxic-ischemic encephalopathy. Indian J Pediatr.2020;87(10):777–778.
5.
MelserSLavieJBenardG. Mitochondrial degradation and energy metabolism. Biochim Biophys Acta.2015;1853(10, pt B):2812–2821.
6.
MerryTLChanAWoodheadJST,et al.Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab.2020;319(4):E659–E666.
7.
WangSLongHHouL,et al.The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther.2023;8(1):304.
8.
ZhaoJLeMLiJ, et al.LINC00938 alleviates hypoxia ischemia encephalopathy induced neonatal brain injury by regulating oxidative stress and inhibiting JNK/p38 MAPK signaling pathway. Exp Neurol.2023;367:114449.
9.
QinXChengJZhongY, et al.Mechanism and treatment related to oxidative stress in neonatal hypoxic-ischemic encephalopathy. Front Mol Neurosci.2019;12:88.
10.
Hernandez-JimenezMSacristanSMoralesC, et al.Apoptosis-related proteins are potential markers of neonatal hypoxic-ischemic encephalopathy (HIE) injury. Neurosci Lett.2014;558:143–148.
11.
BuslKMGreerDM. Hypoxic-ischemic brain injury: pathophysiology, neuropathology and mechanisms. NeuroRehabilitation.2010;26(1):5–13.
MarutaniEMoritaMHiraiS, et al.Sulfide catabolism ameliorates hypoxic brain injury. Nat Commun.2021;12(1):3108.
14.
Manoj KumarLGeorgeRJAnishaPS. Bibliometric analysis for medical research. Indian J Psychol Med.2023;45(3):277–282.
15.
WangRHuangSWangP,et al.Global trends and hotspots in the field of mitochondrial dynamics and hepatocellular carcinoma: a bibliometric analysis from 2007 to 2023. Heliyon.2024;10(2):e24407.
16.
LinJChangYHuM, et al.Global trends in research of mitophagy in liver diseases over past two decades: a bibliometric analysis. Heliyon.2023;9(8):e18843.
17.
SongRGuoYFuY,et al.Trends of mitochondrial changes in AD: a bibliometric study. Front Aging Neurosci.2023;15:1136400.
18.
van EckNJWaltmanL. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics.2010;84(2):523–538.
19.
YeungAWKMozosI. The innovative and sustainable use of dental panoramic radiographs for the detection of osteoporosis. Int J Environ Res Public Health.2020;17(7):2449.
20.
PanXLYanEJCuiMHuaWN. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J Informetr.2018;12(2):481–493.
21.
SynnestvedtMBChenCHolmesJH. Citespace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724–728.
22.
AriaMCuccurulloC. An R-tool for comprehensive science mapping analysis. J Informetr.2017;11(4):959–975.
23.
HuangXFanXYingJChenS. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med.2019;17(1):67.
24.
HagbergHMallardCRoussetCIThorntonC. Mitochondria: hub of injury responses in the developing brain. Lancet Neurol.2014;13(2):217–232.
25.
WuQChenWSinhaB, et al.Neuroprotective agents for neonatal hypoxic-ischemic brain injury. Drug Discov Today.2015;20(11):1372–1381.
26.
HamPB3rdRajuR. Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol.2017;157:92–116.
27.
KristianT. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium.2004;36(3-4):221–233.
28.
ThorntonCJonesANairSAabdienAMallardCHagbergH. Mitochondrial dynamics, mitophagy and biogenesis in neonatal hypoxic-ischaemic brain injury. FEBS Lett.2018;592(5):812–830.
29.
SilachevDNPlotnikovEYPevznerIB, et al.Neuroprotective effects of mitochondria-targeted plastoquinone in a rat model of neonatal hypoxic(-)ischemic brain injury. Molecules.2018;23(8):1871.
30.
ThorntonCHagbergH. Role of mitochondria in apoptotic and necroptotic cell death in the developing brain. Clin Chim Acta.2015;451(pt A):35–38.
31.
LiCWuZXueH,et al.Ferroptosis contributes to hypoxic-ischemic brain injury in neonatal rats: role of the SIRT1/Nrf2/GPx4 signaling pathway. CNS Neurosci Ther.2022;28(12):2268–2280.
32.
PeeplesESGenaro-MattosTC. Ferroptosis: a promising therapeutic target for neonatal hypoxic-ischemic brain injury. Int J Mol Sci.2022;23(13):7420.
33.
ThorntonCBaburamaniAAKichevAHagbergH. Oxidative stress and endoplasmic reticulum (ER) stress in the development of neonatal hypoxic-ischaemic brain injury. Biochem Soc Trans.2017;45(5):1067–1076.
FanHDingRLiuW,et al.Heat shock protein 22 modulates NRF1/TFAM-dependent mitochondrial biogenesis and DRP1-sparked mitochondrial apoptosis through AMPK-PGC1α signaling pathway to alleviate the early brain injury of subarachnoid hemorrhage in rats. Redox Biol.2021;40:101856.
36.
QiHShenDJiangCWangHChangM. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP+-induced Parkinson’s disease. Neurosci Lett.2021;741:135493.
37.
ZengXXuKWangJXuYQuS. Pretreatment of ascorbic acid inhibits MPTP-induced astrocytic oxidative stress through suppressing NF-κB signaling. Neural Plast.2020;2020(1):8872296.
38.
AbateMFestaAFalcoM, et al.Mitochondria as playmakers of apoptosis, autophagy and senescence. Semin Cell Dev Biol.2020;98:139–153.
39.
AngelovaPRAbramovAY. Role of mitochondrial ROS in the brain: from physiology to neurodegeneration. FEBS Lett.2018;592(5):692–702.
40.
LeeEHwangIParkS,et al.MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ.2019;26(2):213–228.
41.
JonesAThorntonC. Mitochondrial dynamics in the neonatal brain—a potential target following injury?Biosci Rep.2022;42(3):BSR20211696.
42.
ZhaoXYLuMHYuanDJ, et al.Mitochondrial dysfunction in neural injury. Front Neurosci.2019;13:30.
43.
Jimenez-DelgadoAOrtizGGDelgado-LaraDL, et al.Effect of melatonin administration on mitochondrial activity and oxidative stress markers in patients with Parkinson's disease. Oxid Med Cell Longev.2021;2021:5577541.
44.
Melhuish BeaupreLMBrownGMGoncalvesVFKennedyJL. Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders. Transl Psychiatry.2021;11(1):339.
45.
TajiriNBorlonganCVKanekoY. Cyclosporine A treatment abrogates ischemia-induced neuronal cell death by preserving mitochondrial integrity through upregulation of the Parkinson's disease-associated protein DJ-1. CNS Neurosci Ther.2016;22(7):602–610.
46.
OkaNWangLXMiWYZhuWHonjoOCaldaroneCA. Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest. J Thorac Cardiov Surg.2008;135(1):123–130, 130.e1-130.e2.
47.
MohammadiAHigazyRGaudaEB. PGC-1alpha activity and mitochondrial dysfunction in preterm infants. Front Physiol.2022;13:997619.
48.
HanBJiangWCuiP, et al.Microglial PGC-1alpha protects against ischemic brain injury by suppressing neuroinflammation. Genome Med.2021;13(1):47.
